December 18, 2012: BioPark News
Noxilizer, Inc. Signs Lease to Relocate to University of Maryland BioPark
- University of Maryland System’s Diverse Space Offerings Provide Sterilization Technology Company the Ability to Grow Locally -
Baltimore, MD, December 18, 2012 – The University of Maryland (UM) BioPark announced today that Noxilizer, Inc., a sterilization technology company, is the latest advancing life sciences company to sign a lease for space within the BioPark. Noxilizer relocates to the UM BioPark from the bwtech@UMBC Research and Technology Park in Baltimore County to accommodate the company’s explansion plans.
Said Jane Shaab, UM Research Park Corporation Senior Vice President, “Noxilizer’s move to the UM BioPark symbolizes the diverse space offerings within the University of Maryland system. This move also adds to our mix of growing technology businesses, research centers, and educational offerings.”
Ellen Hemmerly, Executive Director of the UMBC Research Park Corporation who oversees bwtech@UMBC Research and Technology Park, noted, “It is rewarding to see Noxilizer relocate within the University of Maryland research park system after incubating in our nurturing environment at bwtech@UMBC for the last four years.”
Noxilizer, a privately held company founded in 2004, offers a NO2-based sterilization technology that is designed to revolutionize sterilization practices in both medical device/pharmaceutical/biotechnology manufacturing and in hospitals. In the manufacturing market, Noxilizer provides sterilization services for next-generation medical devices, prefilled syringes and drug/device combination products. Noxilizer also sells the RTS 360 Industrial NO2 Sterilizer to companies that want to sterilize their own products. In hospitals, Noxilizer is developing a system especially for the sensitive, high-tech equipment used in minimally invasive surgical procedures.
“Noxilizer is excited to move its operations as part of our strategy to become a larger part of the greater Baltimore and University of Maryland communities,” said Lawrence Bruder, Noxillizer President & Chief Executive Officer. “The BioPark’s state-of-the-art laboratory facilities will accelerate Noxilizer’s growth by enabling us to operate a high-level microbiology and contract sterilization business for our customers.”
About the University of Maryland BioPark
The UM BioPark is a biomedical research park on the campus of the University of Maryland, Baltimore. The BioPark welcomes additional life science companies to join its growing scientific community of emerging, high-growth life science tenants and University of Maryland (UM) translational research and clinical treatment centers. For early-stage to mature bioscience companies, the BioPark offers a sophisticated laboratory and office environment on the UM’s vibrant academic medical center campus. Community members are commercializing new drugs, diagnostics and devices and advancing biomedical research. Learn more about BioPark tenants at http://www.umbiopark.com/tenants.aspx.
# # #